Original source

Summary

Reuters investigation: China’s Grand Pharmaceutical Group hired Checkmate, a lobbying firm led by Ches McDowell — one of Donald Trump Jr.’s hunting buddies and co-property owner — to argue before CFIUS (the Committee on Foreign Investment in the US) that its investment in Minnesota startup FastWave Communications posed no national security threat. Checkmate secured Grand Pharma’s lawyer a direct meeting with the newly confirmed CFIUS head (Chris Pilkerton); FastWave only got calls with staffers. CFIUS rejected FastWave’s petition in January 2026 on procedural grounds without addressing national security, effectively siding with the Chinese firm. FastWave is now near bankruptcy.

Key Points

  • Grand Pharma (China, 0512.HK) invested $12M in FastWave in 2021 for a 40% stake with veto rights over capital raises.
  • FastWave manufactures laser catheters for treating arterial calcium buildup; the laser technology is export-controlled because it can enhance Chinese military warfare capability.
  • FastWave asked CFIUS in 2025 to force Grand Pharma to divest or become passive; feared IP theft after Grand Pharma partnered with a Chinese rival.
  • Grand Pharma hired Checkmate (led by Don Jr’s hunting buddy Ches McDowell) in December 2025; paid $30,000 for two weeks of work.
  • Checkmate secured Grand Pharma’s lawyer (Jeff Bialos, ex-senior Pentagon official) a direct meeting with CFIUS head Chris Pilkerton in early January 2026.
  • FastWave sought a meeting with Pilkerton twice; only received calls with CFIUS staffers.
  • CFIUS rejected FastWave’s petition in January 2026 on grounds of “material misstatements” — did not address national security risk at all.
  • FastWave near bankruptcy; a fresh petition is not feasible financially.
  • 6 China experts and 3 Democratic lawmakers told Reuters the case raises concerns that Chinese companies could gain influence by hiring Trump-connected lobbyists.
  • Sen. Elizabeth Warren called for answers on who made the decisions and what risk assessments found.
  • White House: “Nothing has changed with CFIUS’s diligence” and any implication of weakened enforcement is “categorically false.”

Newsletter Angles

  • This is the Trump conflict-of-interest machine operating at the national security level, not just financial regulation. The allegation isn’t that Don Jr. did anything — it’s that proximity to him is now a marketable commodity that gives Chinese firms an access advantage in national security proceedings.
  • The “procedural rejection” without addressing national security is the tell: CFIUS didn’t say the deal was safe, they said FastWave filed incorrectly. That’s not a security clearance; it’s a bureaucratic punt that effectively ends the review.
  • “If a Chinese company can lobby the US government into siding with it against an American firm on a national security matter, that is the height of the swamp.” — Michael Sobolik, Hudson Institute (conservative think tank). This isn’t partisan framing — the Hudson Institute is a hawkish conservative institution criticizing Trump’s CFIUS on national security grounds.
  • The laser catheter technology is export-controlled for military dual-use reasons. This isn’t a widget — the specific technology involved has genuine national security implications, which makes the CFIUS non-review even more consequential.

Entities Mentioned

  • Donald Trump — son Don Jr. is linked to Checkmate; White House denied any impropriety
  • Department of Justice — adjacent context (CFIUS is Treasury-led, not DOJ, but the broader accountability pattern connects)

Concepts Mentioned

Quotes

“If a Chinese company can lobby the US government into siding with it against an American firm on a national security matter, that is the height of the swamp.” — Michael Sobolik, Hudson Institute

“Nothing has changed with CFIUS’s diligence, investigation, or enforcement operations, which continue to robustly and vigilantly safeguard America’s national security interests.” — Kush Desai, White House

Notes

  • Reuters investigation with multiple named and anonymous sources, documentary evidence (lobbying filings, CFIUS letter, corporate deed). High-credibility reporting.
  • Reuters explicitly states: “Reuters could not determine if the meeting Checkmate set up played a role in the CFIUS decision.” The causal chain is circumstantial, but the access disparity (Pilkerton meeting vs. staffer calls) is documented.
  • Don Jr. connection is through McDowell (hunting buddy, co-property owner) — Don Jr. is not alleged to have done anything. The story is about proximity as a commodity.
  • The CFIUS rejection on “material misstatements” rather than the merits is the most significant legal detail — it forecloses FastWave’s options without the US government ever saying the investment was safe.